Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System

Re: Cost-Effectiveness Analysis of Sacral Neuromodulation and Botulinum Toxin A Treatment for Patients With Idiopathic Overactive Bladder

The Journal of Urology ◽

10.1016/j.juro.2012.02.2534 ◽

2012 ◽

Vol 187 (6) ◽

pp. 2157-2158

Author(s):

David F. Penson

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Overactive Bladder ◽

Sacral Neuromodulation ◽

Botulinum Toxin A ◽

Toxin A ◽

The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?

BJU International ◽

10.1111/j.1464-410x.2009.08777.x ◽

2009 ◽

Vol 104 (9) ◽

pp. 1188-1190 ◽

Cited By ~ 9

Author(s):

Christopher Chapple ◽

Dirk De Ridder

Keyword(s):

Botulinum Toxin ◽

Overactive Bladder ◽

Sacral Neuromodulation ◽

Botulinum Toxin A ◽

Second Line ◽

Toxin A ◽

Contemporary Practice ◽

Line Management

PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CARE

Value in Health ◽

10.1016/j.jval.2011.02.429 ◽

2011 ◽

Vol 14 (3) ◽

pp. A76-A77

Author(s):

M. Ganz ◽

J.Q. Clemens ◽

J. Anger ◽

S. Denevich ◽

D. Shah ◽

...

Keyword(s):

Botulinum Toxin ◽

Overactive Bladder ◽

Markov Model ◽

Sacral Neuromodulation ◽

Botulinum Toxin A ◽

Toxin A ◽

Conservative Care ◽

Medicare Patients

Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder

BJU International ◽

10.1111/j.1464-410x.2010.09905.x ◽

2010 ◽

Vol 108 (4) ◽

pp. 558-564 ◽

Cited By ~ 50

Author(s):

Randall K. Leong ◽

Stephan G.G. de Wachter ◽

Manuela A. Joore ◽

Philip E.V. van Kerrebroeck

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Overactive Bladder ◽

Sacral Neuromodulation ◽

Botulinum Toxin A ◽

Toxin A ◽

Re: Cost-Effectiveness Analysis of Sacral Neuromodulation and Botulinum Toxin A Treatment for Patients With Idiopathic Overactive Bladder

The Journal of Urology ◽

10.1016/s0022-5347(11)60338-8 ◽

2011 ◽

Vol 186 (1) ◽

pp. 212-213

Author(s):

David F. Penson

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Overactive Bladder ◽

Sacral Neuromodulation ◽

Botulinum Toxin A ◽

Toxin A ◽

Sacral neuromodulation vs botulinum toxin A in refractory idiopathic overactive bladder: review of cost-effectiveness evidence

PharmacoEconomics & Outcomes News ◽

10.1007/s40274-020-7359-3 ◽

2020 ◽

Vol 868 (1) ◽

pp. 27-27

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Overactive Bladder ◽

Sacral Neuromodulation ◽

Botulinum Toxin A ◽

Toxin A

Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder

Yearbook of Urology ◽

10.1016/j.yuro.2011.12.005 ◽

2012 ◽

Vol 2012 ◽

pp. 159-160

Author(s):

E.S. Rovner

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Overactive Bladder ◽

Sacral Neuromodulation ◽

Botulinum Toxin A ◽

Toxin A ◽

Cost Utility Analysis Of Sacral Neuromodulation Versus Botox A In The Treatment Of Overactive Bladder In Colombia

Value in Health ◽

10.1016/j.jval.2014.03.1710 ◽

2014 ◽

Vol 17 (3) ◽

pp. A294

Author(s):

JC Castaño ◽

A. Lopera ◽

J.J. Orozco ◽

J.E. Valencia

Keyword(s):

Overactive Bladder ◽

Sacral Neuromodulation ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis

[29] Time of onset of symptom relief after intraoperative detrusor injection of botulinum toxin A in patients with neurogenic and non-neurogenic overactive bladder syndrome

Arab Journal of Urology ◽

10.1016/j.aju.2018.10.076 ◽

2018 ◽

Vol 16 (sup1) ◽

pp. S14-S15

Author(s):

Awad Thahir ◽

Rawan Al Yousef ◽

Mishari AlMutairi ◽

Ahmad El-Nahas ◽

Abdulateef Al-Terki ◽

...

Keyword(s):

Botulinum Toxin ◽

Overactive Bladder ◽

Botulinum Toxin A ◽

Symptom Relief ◽

Overactive Bladder Syndrome ◽

Toxin A

Paraplegia following intravesical botulinum toxin A (Dysport®) injection for overactive bladder

British Journal of Medical and Surgical Urology ◽

10.1016/j.bjmsu.2009.09.025 ◽

2010 ◽

Vol 3 (2) ◽

pp. 85

Author(s):

Ninaad Awsare ◽

David Jones

Keyword(s):

Botulinum Toxin ◽

Overactive Bladder ◽

Botulinum Toxin A ◽

Toxin A